Vita Coco Company, Inc.
Business
Vita Coco Company is a beverage manufacturer and distributor that pioneered packaged coconut water and has expanded into adjacent plant-based beverages. Its branded portfolio includes Vita Coco coconut water (leader in U.S. and U.K. markets), coconut milk, coconut oil, juice, and PWR LIFT protein-infused sports drink, alongside Private Label coconut water and coconut oil supplied to retailers. The company operates through an asset-light supply chain using contract manufacturers across six countries and distributes through club, food, drug, mass, convenience, e-commerce, and on-premise channels across 35+ countries, with primary markets in North America, the U.K., and Germany.
Summary from 10-K filed 2026-02-18
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net sales | 610 | 516 | 494 | 428 | 380 | |
| Cost of goods sold | 387 | 317 | 313 | 324 | 266 | |
| Gross profit | 223 | 199 | 181 | 103 | 113 | |
| Selling, general and administrative | 140 | 125 | 124 | 100 | 89 | |
| Total operating expenses | 140 | 125 | 124 | 100 | 89 | |
| Income from operations | 83 | 74 | 56 | 3 | 25 | |
| Unrealized gain/(loss) on derivative instruments | 5 | −8 | −872,000 | 7 | 2 | |
| Foreign currency loss | −1 | −2 | −251,000 | 1 | −2 | |
| Interest income, net | 7 | 7 | 3 | 51,000 | 127,000 | |
| Other income | 191,000 | 0 | 0 | — | — | |
| Total other income (expense) | 10 | −3 | 1 | 8 | −360,000 | |
| Income before income taxes | 93 | 71 | 58 | 11 | 24 | |
| Income tax expense | 22 | 15 | 11 | 3 | −5 | |
| Net income | 71 | 56 | 47 | 8 | 19 | |
| Foreign currency translation adjustment | 1 | −211,000 | 345,000 | — | — | |
| Total comprehensive income attributable to The Vita Coco Company, Inc. | — | — | 47 | — | — | |
| Basic (in dollars per share) | 1.25 | 0.99 | 0.83 | 0.14 | 0.35 | |
| Diluted (in dollars per share) | 1.19 | 0.94 | 0.79 | 0.14 | 0.35 | |
| Basic (in shares) | 57 | 57 | 56 | 56 | 54 | |
| Diluted (in shares) | 60 | 59 | 59 | 56 | 54 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 197 | 165 | 133 | 20 | 29 | |
| Accounts receivable, net of allowance of $2,660 at December 31, 2025, and $2,255 at December 31, 2024 | 82 | 63 | 50 | 43 | 47 | |
| Inventory | 111 | 84 | 51 | 84 | 75 | |
| Supplier advances, current | 693,000 | 954,000 | 2 | 2 | 1 | |
| Derivative assets | 732,000 | 1 | 4 | 4 | 126,000 | |
| Prepaid expenses and other current assets | 30 | 27 | 24 | 22 | 21 | |
| Total current assets | 421 | 341 | 263 | 175 | 173 | |
| Property and equipment, net | 9 | 2 | 2 | 2 | 2 | |
| Goodwill | 8 | 8 | 8 | 8 | 8 | |
| Supplier advances, long-term | 2 | 2 | 3 | 4 | 3 | |
| Deferred tax assets, net | 6 | 6 | 7 | 4 | 1 | |
| Right-of-use assets, net | 12 | 385,000 | 1 | 3 | 2 | |
| Other assets | 3 | 2 | 2 | 2 | 2 | |
| Total assets | 461 | 362 | 286 | 198 | 197 | |
| Accounts payable | 25 | 31 | 22 | 16 | 28 | |
| Accrued expenses and other current liabilities | 89 | 66 | 60 | 38 | 42 | |
| Notes payable, current | 3,000 | 10,000 | 13,000 | 23,000 | 28,000 | |
| Derivative liabilities | 2 | 7 | 1 | 71,000 | 3 | |
| Total current liabilities | 116 | 103 | 83 | 54 | 74 | |
| Notes payable, long-term | 0 | 3,000 | 13,000 | 25,000 | 48,000 | |
| Non-current portion of operating lease liabilities | 13 | 0 | — | — | — | |
| Other long-term liabilities | 97,000 | 295,000 | 647,000 | 2 | 301,000 | |
| Total liabilities | 130 | 104 | 83 | 57 | 74 | |
| Contingencies (See Note 11) | — | — | — | — | — | |
| Common stock, $0.01 par value; 500,000,000 shares authorized; 64,186,549 and 63,702,387 shares issued at December 31, 2025 and December 31, 2024, respectively; 57,082,173 and 56,961,941 shares outstanding at December 31, 2025 and December 31, 2024, respectively. | 642,000 | 637,000 | 631,000 | 622,000 | 618,000 | |
| Additional paid-in capital | 185 | 174 | 161 | 145 | 135 | |
| Retained earnings | 228 | 157 | 101 | 55 | 47 | |
| Accumulated other comprehensive gain (loss) | 486,000 | −860,000 | −649,000 | −994,000 | −616,000 | |
| Treasury stock, 7,104,376 shares at cost as of December 31, 2025, and 6,740,446 as of December 31, 2024. | −83 | −72 | −60 | −59 | −59 | |
| Total stockholders equity | 332 | 259 | 202 | 141 | 123 | |
| Total liabilities and stockholders equity | 461 | 362 | 286 | 198 | 197 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 1 | 745,000 | 660,000 | 2 | 2 | |
| Amortization of debt issuance costs | 16,000 | 0 | 0 | — | — | |
| Loss on disposal of equipment | 1,000 | 13,000 | 19,000 | 1,000 | 112,000 | |
| Provision for credit losses | 2 | 2 | 260,000 | 3 | 76,000 | |
| Stock-based compensation | 11 | 9 | 9 | 7 | 3 | |
| Impairment loss on assets held for sale | 0 | 0 | 363,000 | 619,000 | — | |
| Impairment loss on Runa assets | 185,000 | 0 | 0 | 7 | 0 | |
| Noncash lease expense | 1 | 1 | 1 | 1 | 0 | |
| Deferred tax expense | −366,000 | 644,000 | −2 | −3 | −2 | |
| Accounts receivable | −19 | −14 | −7 | 321,000 | −17 | |
| Inventory | −27 | −33 | 34 | −9 | −44 | |
| Prepaid expenses, net supplier advances, and other assets | 130,000 | −3 | −622,000 | −4 | 3 | |
| Accounts payable, accrued expenses, and other liabilities | 11 | 16 | 24 | −17 | 21 | |
| Net cash provided by operating activities | 47 | 43 | 107 | −11 | −16 | |
| Cash paid for property and equipment | −8 | −974,000 | −599,000 | −982,000 | −557,000 | |
| Proceeds from sale of property and equipment | 0 | 0 | 5,000 | 0 | 0 | |
| Equity method investment in joint venture | −104,000 | 0 | 0 | — | — | |
| Net cash used in investing activities | −8 | −974,000 | −594,000 | −982,000 | −557,000 | |
| Proceeds from exercise of stock awards | 4 | 4 | 7 | 3 | 177,000 | |
| Cash paid on notes payable | −10,000 | −13,000 | −23,000 | −28,000 | 21,000 | |
| Cash paid to acquire treasury stock | −11 | −12 | −773,000 | 0 | −50 | |
| Net cash provided by (used in) financing activities | −8 | −8 | 6 | 3 | −27 | |
| Effects of exchange rate changes on cash and cash equivalents | 834,000 | −563,000 | 387,000 | −178,000 | 35,000 | |
| Net increase in cash and cash equivalents | 32 | 33 | 113 | −9 | −43 | |
| Cash paid for interest | 0 | 1,000 | 75,000 | 217,000 | 349,000 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Vita Coco Company, Inc.'s CIK number?
Vita Coco Company, Inc.'s SEC CIK number is 0001482981 (1482981). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Vita Coco Company, Inc.'s SEC filings?
All of Vita Coco Company, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did Vita Coco Company, Inc. last report earnings?
Vita Coco Company, Inc. (COCO) most recently filed an earnings 8-K with the SEC on Apr 29, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001482981-26-000118). This is Vita Coco Company, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is Vita Coco Company, Inc.'s most recent earnings 8-K?
Vita Coco Company, Inc.'s latest earnings 8-K (Item 2.02) was filed Apr 29, 2026 under accession 0001482981-26-000118. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View Vita Coco Company, Inc.'s latest earnings 8-K →
Look up any company's CIK number →